Maximum quantity allowed is 999
请选择数量
CAS RN: 404950-80-7 | 產品號碼: P3137
Panobinostat
×
![]()
×
| 包裝 | 價格 | 同一天 | 2-3个工作日 | 左側以上貨期 |
貨期資訊
|
|---|---|---|---|---|---|
| 10MG |
NT$2,310
|
14 | 20 | 下單後約3-4週內可以出貨 |
* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準，敬請留意。
| 產品號碼 | P3137 |
| 純度/分析方法 | >93.0%(HPLC) |
| 分子式 / 分子量 | C__2__1H__2__3N__3O__2 = 349.43 |
| 外觀與形狀（20°C） | Solid |
| 儲存條件 | Refrigerated (0-10°C) |
| 儲存在惰性氣體下 | Store under inert gas |
| 應避免的情況 | Air Sensitive,Heat Sensitive |
| CAS RN | 404950-80-7 |
| Reaxys-RN | 12257756 |
| MDL編號 | MFCD09833242 |
產品規格
| Appearance | White to Light yellow to Light orange powder to crystal |
| Purity(HPLC) | min. 93.0 area% |
| NMR | confirm to structure |
性質
| 熔點 | 115 °C |
GHS
| 圖形表示 |
|
| 信號詞 | Danger |
| 危險性說明 | H301 : Toxic if swallowed. H361 : Suspected of damaging fertility or the unborn child. H370 : Causes damage to organs. H372 : Causes damage to organs through prolonged or repeated exposure. H341 : Suspected of causing genetic defects. |
| 防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P260 : Do not breathe dust. P270 : Do not eat, drink or smoke when using this product. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P311 : IF exposed or concerned: Call a POISON CENTER/doctor. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P405 : Store locked up. |
相關法規
運輸資料
| UN編號 | UN2811 |
| 類別 | 6.1 |
| 包裝類別 | III |
| HS編碼* | 2933.99-000 |
Application
Panobinostat (LBH589): A Histone Deacetylase (HDAC) Inhibitor
Histone deacetylases (HDACs) catalyze the removal of acetyl groups from the lysine residues of histones and some non-histone proteins and play important roles in maintaining chromatin structure and regulating gene expression, including tumor suppressor genes, and thus represent valid targets in the search for cancer therapeutics. Panobinostat (LBH589) has been reported to inhibit the enzymatic activity of HDACs implicated in cancer and has demonstrated potent anti-tumor activity. (The product is for research purpose only.)
References
- Development of the pan-DAC inhibitor panobinostat (LBH589): Successes and challenges (a review)
- Panobinostat Panobinostat (LBH589): a potent pan-deacetylase inhibitor with promising activity against hematologic and solid tumors (a review)
- Panobinostat: First Global Approval (a review)
- Histone deacetylase inhibitors as anticancer drugs (a review)
產品文件 （部分產品的分析圖譜無法提供，敬請諒解。）
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助，請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注：該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉，您搜索的分析圖譜無法提供。